NASDAQ:SLXN | Free Cash Flow | Silexion Therapeutics Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-06-30 to 2026-06-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-06-30-$2.93M$0.00-$2.93M
2026-03-31-$3.65M$0.00-$3.65M
2025-12-31-$3.02M$2,000.00-$3.02M
2025-09-30-$2.84M$0.00-$2.84M
2025-06-30-$2.51M$1,000.00-$2.51M
2025-03-31-$2.45M$6,000.00-$2.46M
2024-12-31-$2.93M$0.00-$2.93M
2024-09-30-$2.65M$16,000.00-$2.67M
2024-06-30-$1.07M$0.00-$1.07M
2024-03-31-$1.75M$6,000.00-$1.76M
2023-12-31-$1.26M$4,000.00-$1.26M
2023-09-30-$685,000.00$6,000.00-$691,000.00
2023-06-30-$1.68M$2,000.00-$1.68M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.82M$9,000.00-$10.83M
2024-12-31-$8.4M$22,000.00-$8.42M
2023-12-31-$4.53M$12,000.00-$4.54M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.